HemaSphere Journal’s Post

📢 Calling all writers! 🖋️ #EuGMS and #ECGI would like to invite you all to share your personal and local remarkable experiences showing some features of geriatric medicine. We know that each experience is unique, and we believe that each one can indeed contribute to better care for older adult patients. Therefore, sharing your experiences with everyone is extremely important. To submit your blog post to the EuGMS -ECGI Blog you just have to follow these guidelines: ✍️ Write in English, keeping it catchy and concise. 📝 Choose from suggested topics or propose a new one! 🔍 Include references (max 5) and at least 3 keywords. 🖼️ Don‘t forget to attach a royalty-free image. 👨💼👩💼 Share a short bio along with your submission. 📩 Submit your text via the Google form: https://lnkd.in/d7cpZfQU. #EuGMS #GeriatricMedicine #ECGIBlog #WritingOpportunity

In the past two days I posted a question whether those two papers are duplicate or not: 1-OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 tria 2-OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial ==>Despite that both papers have ~ the same authors, treatment arms (dosage, timing,..etc) and recruitment period --- they are not considered duplicate population. When you go to their protocol published in clinicaltrials.gov, you will find that the trial location is different (attached screen shot) Note that the same trial could have two different registration numbers See https://lnkd.in/d2gi9SaD So you have to check every paper well before taking the exclusion decision especially when you have small number of included papers. #research #medicalresearch #publication #duplicate #systematicreview #metaanalysis #publichealth #editor

📢 Late-breaking Abstract Submission Deadline Is Approaching! EPUAP has decided to provide the opportunity to submit late-breaking abstracts including studies with results that were not available in the regular submission period. Do you want to present your work and discuss your topic closely in one of the focused free paper sessions with colleagues from all over the world? Submit your abstract by the 31st of May! 📅 Abstracts covering both #practice and #research areas are welcome! More information available on: epuap2024.org/abstracts #stoppressureulcers #pressureulcers #stopthepressure #woundcare #EPUAP #Lausanne

Call for Papers: Biopolymer Materials for Wound Healing, 3rd Edition We invite you to contribute to the 3rd Edition of our Special Issue, Biopolymer Materials for Wound Healing, in the journal Pharmaceutics. Building upon the success of the previous editions, which featured 11 and 8 articles, respectively, this special issue aims to showcase the latest advancements in the field. Edited with my esteemed colleague and friend Gorka Orive Pharmaceutics MDPI https://lnkd.in/d_EuVugs

𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐏𝐚𝐩𝐞𝐫𝐬 𝐄𝐱𝐩𝐥𝐚𝐢𝐧𝐞𝐝 – 𝐟𝐢𝐫𝐬𝐭 𝐩𝐚𝐩𝐞𝐫 𝐭𝐫𝐚𝐧𝐬𝐥𝐚𝐭𝐞𝐝! “𝐄𝐱𝐩𝐞𝐫𝐢𝐞𝐧𝐜𝐞𝐬 𝐨𝐟 𝐜𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐭𝐫𝐢𝐚𝐥𝐬 𝐢𝐧 𝐡𝐨𝐦𝐞𝐬 𝐚𝐧𝐝 𝐥𝐨𝐜𝐚𝐥 𝐬𝐞𝐭𝐭𝐢𝐧𝐠𝐬 𝐨𝐮𝐭𝐬𝐢𝐝𝐞 𝐨𝐟 𝐜𝐥𝐢𝐧𝐢𝐜𝐬 – 𝐚 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐩𝐫𝐨𝐣𝐞𝐜𝐭 𝐮𝐬𝐢𝐧𝐠 𝐢𝐧𝐭𝐞𝐫𝐯𝐢𝐞𝐰𝐬” WP CODE has recently formed a working group to translate technical/scientific documents into plain language for the general public including patients. It’s intended for those interested in learning more about decentralised clinical trials (DCT) in a more accessible and easily digestible format. The aim of this group is to foster accessibility of the Trials@Home materials, to increase awareness and educational opportunities surrounding DCTs. The group has now finished the translation of the first paper “Learning from remote decentralised clinical trial experiences: A qualitative analysis of interviews with trial personnel, patient representatives and other stakeholders” Download the translation here -> https://bit.ly/3Xz5vdz

𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐏𝐚𝐩𝐞𝐫𝐬 𝐄𝐱𝐩𝐥𝐚𝐢𝐧𝐞𝐝 – 𝐟𝐢𝐫𝐬𝐭 𝐩𝐚𝐩𝐞𝐫 𝐭𝐫𝐚𝐧𝐬𝐥𝐚𝐭𝐞𝐝! “𝐄𝐱𝐩𝐞𝐫𝐢𝐞𝐧𝐜𝐞𝐬 𝐨𝐟 𝐜𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐭𝐫𝐢𝐚𝐥𝐬 𝐢𝐧 𝐡𝐨𝐦𝐞𝐬 𝐚𝐧𝐝 𝐥𝐨𝐜𝐚𝐥 𝐬𝐞𝐭𝐭𝐢𝐧𝐠𝐬 𝐨𝐮𝐭𝐬𝐢𝐝𝐞 𝐨𝐟 𝐜𝐥𝐢𝐧𝐢𝐜𝐬 – 𝐚 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐩𝐫𝐨𝐣𝐞𝐜𝐭 𝐮𝐬𝐢𝐧𝐠 𝐢𝐧𝐭𝐞𝐫𝐯𝐢𝐞𝐰𝐬” WP CODE has recently formed a working group to translate technical/scientific documents into plain language for the general public including patients. It’s intended for those interested in learning more about decentralised clinical trials (DCT) in a more accessible and easily digestible format. The aim of this group is to foster accessibility of the Trials@Home materials, to increase awareness and educational opportunities surrounding DCTs. The group has now finished the translation of the first paper “Learning from remote decentralised clinical trial experiences: A qualitative analysis of interviews with trial personnel, patient representatives and other stakeholders” Download the translation here -> https://bit.ly/3Xz5vdz

📰"Real-World Evaluation of the Tolerability to #OnabotulinumToxin A: The RETO Study" is an article published in #mdpitoxins. Read this feature paper at: https://lnkd.in/eM33PyEm

PETITION: ME/CFS: Changing the Definition - Please consider signing and sharing this petition "Elsevier (publisher) - Petition to request updating of the description of ME/CFS in Kumar and Clark’s Clinical Medicine textbook. We the undersigned, request that the next edition of Kumar and Clark’s Clinical Medicine, due in 2025, address 5 points." (as outlined on the petition page) Read the details in full and sign here: https://chng.it/RcJMZDDjNG #pwME #MECFS #MyalgicE #MyalgicEncephalomyelits #MedicalTextBook #MedicalEducation #Petition

PETITION: ME/CFS: Changing the Definition - Please consider signing and sharing this petition "Elsevier (publisher) - Petition to request updating of the description of ME/CFS in Kumar and Clark’s Clinical Medicine textbook. We the undersigned, request that the next edition of Kumar and Clark’s Clinical Medicine, due in 2025, address 5 points." (as outlined on the petition page) Read the details in full and sign here: https://chng.it/RcJMZDDjNG #pwME #MECFS #MyalgicE #MyalgicEncephalomyelits #MedicalTextBook #MedicalEducation #Petition